Ganyan1

Beijing Tongren Hospital · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Ganyan1
Sponsor	Beijing Tongren Hospital
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Ganyan-1 in Dry Eye (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ganyan1 CI brief — competitive landscape report
Ganyan1 updates RSS · CI watch RSS
Beijing Tongren Hospital portfolio CI